CRY2 and colorectal carcinoma: Expectedly, suppression of CRY2 activity could be an effective mean to increase the efficacy of chemotherapy in CRC, as evidenced by the study showing that CRY2 knockdown increased the sensitivity to oxaliplatin in CRC cell lines.